Volume 44, Issue 3, Pages (March 2006)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 61, Issue 2, Pages (August 2014)
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Volume 356, Issue 9230, Pages (August 2000)
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
MELD: the holy grail of organ allocation?
m-TOR inhibitors: What role in liver transplantation?
MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis  Wichit Srikureja,
m-TOR inhibitors: What role in liver transplantation?
Volume 68, Issue 5, Pages (May 2018)
Primary prevention of variceal haemorrhage: A pharmacological approach
Volume 61, Issue 6, Pages (December 2014)
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Immigration and viral hepatitis
Marcus-Alexander Wörns, Peter Robert Galle  Journal of Hepatology 
Volume 66, Issue 1, Pages 1-4 (January 2017)
The evidence supports a viral aetiology for primary biliary cirrhosis
Living donor liver transplantation: is the hype over?
What lessons have we learned in pediatric liver transplantation?
Reply to: “DCD consensus and futility in liver transplantation”
Volume 44, Pages S19-S24 (January 2006)
Transplantation for alcoholic liver disease
The place of downstaging for hepatocellular carcinoma
Volume 58, Issue 3, Pages (March 2013)
Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure”  Rakhi Maiwall,
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Familial amyloid polyneuropathy and liver transplantation
Hepatitis C core protein – The “core” of immune deception?
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 62, Issue 3, Pages (March 2015)
Volume 43, Issue 4, Pages (October 2005)
Volume 55, Issue 2, Pages (August 2011)
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Volume 41, Issue 4, Pages (October 2004)
The changing role of beta-blocker therapy in patients with cirrhosis
Volume 65, Issue 2, Pages (August 2016)
Volume 57, Issue 5, Pages (November 2012)
Paul C. Adams, James C. Barton  Journal of Hepatology 
Immunosuppression in liver transplant recipients with renal impairment
Volume 50, Issue 3, Pages (March 2009)
Immigration and viral hepatitis
Volume 57, Issue 3, Pages (September 2012)
Evolution of liver transplantation for hepatocellular carcinoma
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
The impact of intestinal microflora on serum bilirubin levels
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection  Isabelle Chemin,
Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice  Paolo Angeli, Pere Gines 
Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence  Christian Toso, Gilles Mentha, Pietro.
Volume 66, Issue 4, Pages (April 2017)
m-TOR inhibitors: What role in liver transplantation?
New trials and results in systemic treatment of HCC
Volume 46, Issue 3, Pages (March 2007)
Liver transplantation in children
Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi 
Pathogenesis of cholestatic hepatitis C
Donor-recipient matching: Myths and realities
Chimeric mouse model of hepatitis B virus infection
MELD: the holy grail of organ allocation?
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Presentation transcript:

Volume 44, Issue 3, Pages 520-528 (March 2006) Liver transplantation for Budd–Chiari syndrome: A European study on 248 patients from 51 centres  Gilles Mentha, Emiliano Giostra, Pietro E. Majno, Wolf O. Bechstein, Peter Neuhaus, John O'Grady, Raaj K. Praseedom, Andrew K. Burroughs, Yves P. Le Treut, Preben Kirkegaard, Xavier Rogiers, Bo-Goran Ericzon, Krister Hockerstedt, René Adam, Juergen Klempnauer  Journal of Hepatology  Volume 44, Issue 3, Pages 520-528 (March 2006) DOI: 10.1016/j.jhep.2005.12.002 Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Distribution of mortality after transplantation according to the date of death (67/248 patients). Journal of Hepatology 2006 44, 520-528DOI: (10.1016/j.jhep.2005.12.002) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Survival of the 248 patients transplanted for BCS in the study (Kaplan–Meier). Journal of Hepatology 2006 44, 520-528DOI: (10.1016/j.jhep.2005.12.002) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Survival of patients according to renal function at transplantation: normal (serum creatinine ≤120μMol/L), mildly impaired (serum creatinine ≤160μMol/L), severely impaired (serum creatinine >160μMol/L or dialysis). Journal of Hepatology 2006 44, 520-528DOI: (10.1016/j.jhep.2005.12.002) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions